Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
1.540
-0.030 (-1.91%)
At close: Oct 14, 2025, 4:00 PM EDT
1.550
+0.010 (0.65%)
After-hours: Oct 14, 2025, 7:34 PM EDT
Mainz Biomed Market Cap
Mainz Biomed has a market cap or net worth of $6.30 million as of October 14, 2025. Its market cap has increased by 34.60% in one year.
Market Cap
6.30M
Enterprise Value
7.40M
1-Year Change
34.60%
Ranking
Category
Stock Price
$1.54
Market Cap Chart
Since the IPO on November 5, 2021, Mainz Biomed's market cap has decreased from $58.55M to $6.30M, a decrease of -89.24%. That is a compound annual growth rate of -43.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 6.42M | -55.86% |
| Dec 31, 2024 | 14.55M | -38.37% |
| Dec 29, 2023 | 23.62M | -77.05% |
| Dec 30, 2022 | 102.90M | -17.54% |
| Dec 31, 2021 | 124.78M | 113.12% |
| Nov 5, 2021 | 58.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |